Gender affirming hormonal therapy: management by the hormone-prescribing doctor.
Seance of wednesday 19 april 2023 (La chirurgie transgenre)
DOI number : 10.26299/x285-9j07/emem.2023.15.03
Abstract
Medical care for transgender patients is still characterized by an insufficient availability of healthcare services, as well as poor provider education and training. Transgender patients often require gender-affirming hormone therapy (GAHT), and physicians - including endocrinologists, general practitioners, and others-, should be trained to initiate and monitor these treatments throughout the transition process, and beyond. This presentation will address the specific issues surrounding GAHT in adult transgender women and men.